IQVIA™ Real-World Insights Bibliography

Patrones de tratamiento biológico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 años de seguimiento
Author(s): Juan D. Cañete1, Antonio Naranjo2, Javier Calvo3, Carmen Ordás4, Belén Aragón5, Gonzalo Nocea5, Montse Roset6, Antonio Fernández-Nebro7
Affiliations(s): 1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, España 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, España 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, España 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, España 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, España 6 Departamento de Health Economics and Outcomes Research, IQVIA, Barcelona, España 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, España
Publication(s):  Reumatología Clínica, 2019. DOI: 10.1016
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Drug Utlization Study,
2019
  L:
A:
Spanish
Clinical setting: hospital, Observational study,
  Add to report
 
 
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe
Author(s): Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U
Affiliations(s): Fife: Janssen Research and Development, LLC Waller: Adephi Real World Kaplan: Teva Pharmaceutical Indusries Ltd. Hu: Janssen Global Services Phillips: IQVIA Oliveria, IQVIA Richarz: Janssen Research and Development, LLC
Publication(s):  Clin Drug Investig (2019). https://doi.org/10.1007/s40261-019-00831-3
Document Type(s): Article,
Countries: Belgium, France, Germany, Spain, UK,
Click here for the abstract
C:
Y:
Drug safety, Drug Utlization Study,
2019
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
A population-based analysis of anti-diabetic medications in four Canadian provinces: secular trends and prescribing patterns
Author(s): Secrest MH, Azoulay L, Dahl M, Clemens KK, Durand M, Hu N, Targownik L, Turin TC, Dormuth CR, and Filion KB
Affiliations(s): IQVIA, Cambridge, MA
Publication(s):  Pharmacoepidemiology & Drug Safety (in press)
Document Type(s): Article, In press/to be published,
Countries: Canada,
C:
Y:
Diabetes, Drug Utlization Study,
2019
  L:
A:
English
Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
5-ASA Prescription Trends over Time in Inflammatory Bowel Disease 1996 to 2015-A UK Population-Based Study
Author(s): Jaraith, V, S Hokkanen, L Guizzetti, N Boxall, S Campbell-Hill, and H Patel
Affiliations(s): Western University, Department of Medicine, London, Ontario, Canada, Robarts Clinical Trials Inc., London, Ontario, Canada, IQVIA, London, UK,
Publication(s):  Journal of Crohn, no. Supplement 1 (February): S309?10
Document Type(s): Abstract,
Countries: UK,
Click here for the abstract
C:
Y:
Clinical practice, Drug Utlization Study, Gastrointestinal disorders,
2018
  L:
A:
English
Epidemiological study, Retrospective cohort analysis,
  Add to report
 
 
The Impact of Risk Minimization Measures on Compliance and Prescribing Practices of Flupirtine in Germany.
Author(s): Kaplan S, Ehlken B, Hamann X
Affiliations(s): Teva Pharmaceutical Industries Ltd , Petach Tikva , Israel. IQVIA (formerly IMS Health) , Munich , Germany. Ratiopharm GmbH (an affiliate of Teva Pharmaceuticals Europe BV) , Ulm , Germany
Publication(s):  Curr Med Res Opin
Document Type(s): Article,
Countries: Germany,
C:
Y:
Drug Utlization Study, Medication compliance,
2018
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Treatment Patterns, Adherence, and Persistence among Psoriasis Patients Treated with Biologics in a Real-World Setting, Overall and by Disease Severity
Author(s): Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Zbrozek A, Araujo AB
Affiliations(s): Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Casso D: IQVIA; Ojeh CK: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Merola JF: cBrigham and Women?s
Publication(s):  Journal of Dermatological Treatment
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods,
2018
  L:
A:
English
Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
Real-World Use of Dulaglutide in Europe: A Multi-Country Drug Utilization Study
Author(s): Ali AK, Toussi M, Phillips S, Roste M
Affiliations(s): Ali AK: Eli Lilly and Company; Toussi M: IQVIA; Phillips S: IQVIA; Roste M: IQVIA
Publication(s):  34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Type(s): Abstract,
Countries: France, Germany, Spain, Sweden,
C:
Y:
Diabetes, Drug Utlization Study, Drug Utlization Study,
2018
  L:
A:
English
Database Study, Epidemiological study,
  Add to report
 
 
Adherence and Persistence to Biologics Among Psoriasis Patients, Overall and by Disease Severity
Author(s): Murage MJ, Anderson A, Oliveria SA, Al Sawah S, Casso D, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB
Affiliations(s): Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Al Sawah S: Eli Lilly and Company; Casso D: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Ojeh CK: Eli Lilly and Company; Zbrozek A: Eli Lilly and Company, Araujo AB: Eli Lilly and Company
Publication(s):  34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Type(s): Abstract,
Countries: USA,
C:
Y:
Database Validity and methodology, Dermatology, Drug Utlization Study, Urology,
2018
  L:
A:
English
Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
Healthcare Resource Utilization and Costs Among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity
Author(s): Al Sawah S, Anderson A, Casso D, Murage MJ, Oliveria SA, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB
Affiliations(s): Al Sawah S: Eli Lilly and Company; Anderson A: IQVIA; Casso D: IQVIA; Murage MJ: Eli Lilly and Company; Oliveria SA: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM, Ojeh CK: Eli Lilly and Company; Zbrozek A, Araujo AB: Eli Lilly and Company
Publication(s):  34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Type(s): Abstract,
Countries: USA,
C:
Y:
Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods,
2018
  L:
A:
English
Database Study, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Chapter 4.1 Drug Utilisation and Prescription-Event Monitoring
Author(s): Massoud Toussi and Deborah Layton
Affiliations(s): IQVIA, Cedex France; IQVIA, London
Publication(s): 
Document Type(s): Book chapter,
Countries: England,
C:
Y:
Drug Utlization Study,
2018
  L:
A:
English
Epidemiological study,
  Add to report
 
 
 1 of 3 Next Page Last Page